The Delhi High Court on Monday directed the central government to decide "as early as possible" a representation by an NGO for priority in COVID vaccination to NRIs and students who have to go abroad for studies.
A bench of Chief Justice D N Patel and Justice Jyoti Singh said the representation of May 20 by NGO Pravasi Legal Cell be decided in accordance with the law, rules, regulations and government policy applicable to the case.
With the direction, the court disposed of the PIL.
The NGO had moved the court as it received no response to its representation.
The NGO, represented by advocate Jose Abraham, had also sought inclusion of passport numbers in the vaccination certificates of those intending to travel abroad.
Pravasi Legal Cell, in its plea filed through advocates M P Srivignesh, Robin Raju and Deepa Joseph, claimed that NRIs who came to India during the COVID-19 outbreak globally have to now return to their respective countries where they reside or work in view of decline in infections in many countries and resumption of international flights.
However, foreign nations only allow entry to those persons who are vaccinated and if preference is not given to such individuals, it would badly affect them, the petition said.
It also said that the US and European countries are only permitting entry to those students who have been vaccinated and therefore, it was important to give priority to such persons as the academic year in the US, the UK and other European nations commences from August-September.
It had further said that most foreign countries accept the vaccination certificate only when they have the passport number on it.
"So, a vaccination certificate carrying the Aadhaar number in place of the passport number cannot be produced as a valid document with the latest rules in many countries," it had added.
It had also claimed that people who have received both doses of Covaxin are also not allowed to travel internationally as the vaccine, manufactured by Bharat Biotech, has not been included in the World Health Organization's (WHO) Emergency Use Listing (EUL) yet.
"So, it is humbly submitted that the respondent (Centre) must take appropriate steps in this regard so no difficulty is faced by the people travelling abroad even after being fully vaccinated by doses of Covaxin," it had said.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)